PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 5 days 20 hours 52 minutes
Evolution of Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Approaches to Management
Visit https://www.peervoice.com/QFW860 to view the entire programme with slides.
Immuno-oncology for mRCC: Considerations for a Combination Approach in the First-Line Setting
Visit https://www.peervoice.com/GYG860 to view the entire programme with slides.
Recognising and Addressing Burden of Disease in Adolescents With Moderate-to-Severe AD
Visit https://www.peervoice.com/MVJ860 to view the entire programme with slides.
Heading Toward a More Successful Approach to Migraine Management
Heading Toward a More Successful Approach to Migraine Management
Choose Your Own HS Adventure: Going Beyond Current Guidelines
Choose Your Own HS Adventure: Going Beyond Current Guidelines
Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment
Visit https://www.peervoice.com/BPE860 to view the entire programme with slides.
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?
Visit https://www.peervoice.com/CSE860 to view the entire programme with slides.
Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes
Visit https://www.peervoice.com/AAB860 to view the entire programme with slides.
The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma
Visit https://www.peervoice.com/JFV860 to view the entire programme with slides.